![[Herald Interview] Lotte Biologics' US plant to begin ADC services in early 2025 - Vimarsana News](https://res.heraldm.com/content/image/2024/01/10/20240110000632_0.jpg?1)
[Herald Interview] Lotte Biologics' US plant to begin ADC services in early 2025
SAN FRANCISCO -- Lotte Biologics will begin production of its antibody-drug conjugates at its US plant by the first quarter of 2025, according to its CEO Richard Lee, who spoke at a meeting with reporters on Monday, held on the sidelines of the J.P. Morgan Healthcare Conference. As ADCs have emerged as a promising class of treatments, the Korean contract drug manufacturer has received a myriad of requests from potent...
Source: koreaherald.com